ArticleMolecular biology reports2025
A FSHR missense variant associated with polycystic ovary syndrome in an Iranian family with multiple affected sisters.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Methodological considerations for FSHR variant interpretation in PCOS.Molecular biology reports · 2025Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder affecting 5-15% of women of reproductive age and is a leading cause of female infertility. It is a complex, multifactorial condition in which genetic factors play a significant role and may affect siblings within a family. Here, we present the case of two infertile sisters from an Iranian family. METHODS AND
resultsTwo sisters with treatment-resistant infertility and a history of PCOS underwent comprehensive genetic evaluation. Whole exome sequencing (WES) was performed on one of the sisters, and identified a missense variant, rs745386710, which is located in exon 5 of the FSHR gene, resulting in the p.L149F substitution. Sanger sequencing confirmed the presence of this variant in the other affected sister. variant interpretation was conducted in accordance with the guidelines of the American College of Medical Genetics and Genomics (ACMG). Structural protein analysis indicated that this variant may reduce protein-protein affinity. Importantly, we provide the first functional evidence for this variant.
conclusionThis variant appears to significantly reduce protein stability and impair binding to follicle-stimulating hormone (FSH) and its receptor (FSHR), which may inhibit follicular maturation and contribute to the pathogenesis of PCOS.
Indexed as
Identifiers
41148487What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.